LEO Innovation

LEO Innovation Lab, founded in 2015 and based in Copenhagen, Denmark, focused on developing innovative solutions to enhance the quality of life for individuals with skin conditions. The organization operated as an accelerator and incubator, fostering projects aimed at addressing the challenges faced by people living with these conditions. However, the firm ceased its operations on May 23, 2023. Throughout its existence, LEO Innovation Lab aimed to leverage technology and research to create impactful products and services in the dermatological field.

8 past transactions

Centaur Labs

Seed Round in 2019
Our platform uses trained professionals to analyze medical images and videos, enabling our customers to build new technologies and treatments to detect and fight disease.

Combinostics

Seed Round in 2017
Combinostics Oy is a Finnish company founded in 2014, specializing in advanced diagnostic tools aimed at neurodegenerative diseases. The company develops software solutions that support clinical decision-making by providing quantitative assessments of brain images, including MR, PET, and CT scans. Through its cloud-based platform, Combinostics offers healthcare professionals a comprehensive view of patient data, facilitating early diagnosis and enhancing treatment outcomes for neurological disorders. By integrating imaging biomarker solutions with clinical decision support, Combinostics aims to improve the accuracy and efficiency of diagnostics in the healthcare sector.

TalkLife

Seed Round in 2017
TalkLife is a social network that’s saving lives - a mobile platform tackling the global youth mental health crisis. Talklife is fast becoming an industry innovator by embracing smartphone technology and creating a pathway that encourages youth to become transparent with their struggles in an accepting and positive environment, shining light on taboo topics such as depression, self harm and suicide.

Remedly

Seed Round in 2017
Cloud-based, data-centric ERP system for physicians and their patients. Remedly provides medical practices with an integrated Practice management / EHR / Revenue Cycle Management / Marketing / Analytics solution and their patients with a comprehensive online concierge service.

SkinVision

Series A in 2017
SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.

Pacifica Labs

Seed Round in 2017
Pacifica Labs, Inc. is a San Francisco-based company that develops a mobile application aimed at helping individuals manage stress, anxiety, and worry through cognitive behavioral therapy and mindfulness techniques. Founded in 2014, the Pacifica application offers users tools for daily mood tracking, guided relaxation exercises, and peer support groups, making mental health care more accessible and integrated into everyday life. By employing engaging and evidence-based strategies, the app empowers users to take control of their mental well-being, thereby reducing the financial burden on both individuals and healthcare providers. The platform is designed for both those currently in treatment and those who may not otherwise seek care, fostering a proactive approach to mental health maintenance.

TalkLife

Seed Round in 2016
TalkLife is a social network that’s saving lives - a mobile platform tackling the global youth mental health crisis. Talklife is fast becoming an industry innovator by embracing smartphone technology and creating a pathway that encourages youth to become transparent with their struggles in an accepting and positive environment, shining light on taboo topics such as depression, self harm and suicide.

Combinostics

Seed Round in 2016
Combinostics Oy is a Finnish company founded in 2014, specializing in advanced diagnostic tools aimed at neurodegenerative diseases. The company develops software solutions that support clinical decision-making by providing quantitative assessments of brain images, including MR, PET, and CT scans. Through its cloud-based platform, Combinostics offers healthcare professionals a comprehensive view of patient data, facilitating early diagnosis and enhancing treatment outcomes for neurological disorders. By integrating imaging biomarker solutions with clinical decision support, Combinostics aims to improve the accuracy and efficiency of diagnostics in the healthcare sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.